ARCHIVES

Study Tests PARP Inhibitor ABT-888 For Several Cancers

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Delays NDA On BCNU, But New Drug Seminar Still Scheduled

November 28, 1975

Calcium, Vitamin D Provide No Benefit for Colon Cancer

February 24, 2006

NCAB Approves Concept Of Four Contract Program

May 29, 1981

NCI Grant Boosts UCLA Bladder Cancer Project

October 25, 2002

Leffall New ACS President, Gudberg, President-Elect

November 17, 1978

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

October 3, 2008